Skip to main content
Neuland Labs

Main navigation

  • CDMO Services
    • Small Molecules
    • Peptides
  • Generic APIs
    • API Products
    • Download Brochure
  • Our Capabilities
    • Chemistry & Reactions
    • Peptide Technologies
    • Lifecycle Management (Phase-Appropriate Development)
    • Quality & Regulatory Compliance
    • Technology Transfer
    • Analytical Expertise
    • Process Safety & Engineering
  • Contact us
User account menu
  • Log in
By admin, 3 November, 2026

Q2 – FY 27 Investor Call Recording

Investor Call Recordings
2026-27
Q2
Audio
NeulandLab-Earnings-Nov03-2026Audio.mp3 (32.45 MB)
By admin, 3 November, 2026

Neuland Press Release Q2 FY27

Disclosures to Stock Exchange
2026-27
Q2
PDF
Q2FY27_Press_Release_Neuland_Lab_vF.pdf (384.18 KB)
By admin, 3 November, 2026

Neuland Investor Presentation Q2 FY27

Investor Presentations
2026-27
Q2
PDF
Q2FY27_Investor_Presentation_Neuland Laboratories_vF.pdf (2.36 MB)
By admin, 3 November, 2026

Outcome of Board Meeting – 03/11/2026

Board Meeting
2026-27
Q2
PDF
SEOutcome_03112026.pdf (659.98 KB)
By subhendu, 29 October, 2026

Intimation of Loss of Share Certificates (29-10-2026)

Duplicate Share Certificates
2026-27
PDF
SE-Intimation-Loss-of-Share-Certificate_29-10-2026.pdf (283.34 KB)
By subhendu, 28 October, 2026

Neuland Q2FY27 Earnings Call Invite

Analyst Meets
2026-27
Q2
PDF
Neuland-Q2FY27-Earnings-Call-Invite.pdf (197.43 KB)
By subhendu, 28 October, 2026

Risk Management Policy

Policies and Documents
2026-27
PDF
NLL_Risk-Management-Policy_15-05-2025.pdf (221.34 KB)
By subhendu, 23 October, 2026

BM Intimation Q2FY27

Board Meeting
2026-27
Q2
PDF
BM-Intimation-Q2FY27.pdf (276.09 KB)
By subhendu, 12 October, 2026

Shareholding Pattern for Q2FY27

Shareholding Pattern
2026-27
Q2
PDF
Shareholding-Pattern_Q2FY27.pdf (256.75 KB)
By subhendu, 1 October, 2026

BPS2025

Pagination

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page
  • Last page
RSS feed
Powered by Drupal